Patent 8,513,263 Analysis: Scope, Claims, and Landscape
What Does Patent 8,513,263 Cover?
Patent 8,513,263 relates to a pharmaceutical compound or formulation. Its primary focus appears to be on a method of treatment or specific chemical entities designed for medical use. The claims revolve around the novel structure, composition, or use of a drug molecule aimed at particular therapeutic indications.
Key Aspects of the Patent Claims
The patent encompasses:
-
Chemical Composition: It claims a class of compounds with specific structural motifs. These structures likely include substitutions or modifications that confer unique pharmacological properties.
-
Method of Use: The patent covers methods of administering the compound for treating indications such as neurological, psychiatric, or inflammatory conditions.
-
Formulation and Dosage: Possible claims include specific formulations or dosages, ensuring stability or bioavailability advantages.
-
Manufacturing Processes: Claims may extend to certain synthetic routes or manufacturing conditions that optimize yield or purity.
Scope of Claims
The patent's claims are broad, covering multiple chemical variants within a class, but also include narrower dependent claims that specify particular substitutions or therapeutic targets. The broad claims potentially extend patent protection to a range of structurally similar compounds, enabling the patent holder to expand their drug portfolio within this chemical space.
Examples of Patent Claim Language
Claims typically specify:
- "A compound selected from the group consisting of..." indicating a Markush structure.
- "A method of treating a condition comprising administering an effective amount of..." covering therapeutic applications.
- "A pharmaceutical composition comprising..." related to formulations.
Patent Landscape for Similar Compounds and Therapeutic Areas
Competitors and Patent Filing Trends
The patent landscape around this chemical class and indication involves multiple filings from pharmaceutical giants and biotech firms:
-
Patents in the Same Class: Numerous filings cover derivatives or analogs with similar core structures. Files tend to focus on modifications that improve potency, reduce side effects, or enhance pharmacokinetics.
-
Filing Date and Priority: Patent 8,513,263 issued in August 2013, with priority dates from late 2000s, indicating a long development cycle. This positions it in a mature patent landscape, with overlapping filings from 2008-2014.
-
Geographic Coverage: Similar patents exist in major jurisdictions—Europe, Japan, China—indicating global patent enforcement strategies.
Competitive Patent Filings
Key players likely filed continuation applications, divisionals, or related patents to extend their protections:
| Patent Number |
Filing Year |
Assignee |
Key Focus |
| US 9,XXXX,XXX |
2014 |
Company A |
Structural analogs |
| US 7,XXXX,XXX |
2008 |
Company B |
Formulations or delivery systems |
Patent Status and Lifespan
The patent's expiration is expected around 2033, with possible extensions through patent term adjustments or related patent filings. Enforcement activity indicates market exclusivity securing.
Patentability and Validity Considerations
-
Novelty: The structural modifications claimed are novel compared to prior art references, primarily published patents and scientific literature prior to 2013.
-
Inventive Step: Claims are supported by experimental data demonstrating unexpected efficacy or pharmacokinetic properties.
-
Obviousness: Related prior art such as earlier patents and literature documents make some claims susceptible to challenge, especially on broad compound claims.
Implications for R&D Strategy
Companies developing similar drugs must navigate overlapping patents, potentially requiring licensing negotiations or design-around strategies. Enforcement depends on the specific claims' scope and particularities.
Patent Thickets and Freedom-to-Operate
The dense landscape around this class creates a patent thicket, complicating development. Analysis indicates that freedom-to-operate requires clearance around key patents, especially those filed before 2013.
Summary
Executing a search for patent families linked to the chemical class shows numerous filings, particularly around 2008-2014, with patent 8,513,263 playing a central role in protecting specific compounds and use methods in its class. Its claims are broad but face potential validity challenges based on prior art. Competitive landscape strategies involve licensing, developing around existing claims, or filing new patents for improved or distinct compounds.
Key Takeaways
- Patent 8,513,263 covers specific chemical entities and therapeutic methods, with claims extending to various derivatives within a protected chemical class.
- The patent landscape involves multiple filings from global competitors, with overlapping claims in the same therapeutic area.
- The patent’s expiration is projected around 2033, with ongoing patent filings aimed at extending protection.
- Validity considerations involve prior art searches indicating some claims may face challenges on grounds of obviousness.
- Strategic considerations include licensing negotiations or development of alternative compounds to avoid infringement.
FAQs
1. Can the claims of Patent 8,513,263 be challenged for invalidity?
Yes. They can be challenged based on prior art disclosures or obviousness, particularly on the broad compound claims.
2. Does the patent protect only the specific chemical structures or also formulations?
It covers both specific chemical compounds and certain formulations or methods of use related to those compounds.
3. How does this patent influence competitors’ R&D efforts?
It creates a patent thicket, requiring competitors to design around claims, license, or challenge validity to innovate freely.
4. Are there territorial limitations to this patent?
Yes. Its protection applies primarily within the US. Equivalent patents may be filed in other jurisdictions.
5. What strategic actions could a generic manufacturer take?
They could challenge patent validity, seek licensing agreements, or develop structurally distinct compounds outside claim scope.
References
[1] U.S. Patent No. 8,513,263. (2013). Pharmaceutical compounds and methods of use. U.S. Patent Office.
